COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,253 Articles (22,733 medRxiv, 8,520 bioRxiv)

Most recent first Previous |  Page 1678: Articles 16771-16780  | Next

Viability RT-PCR for SARS-CoV-2: a step forward to solve the infectivity quandary
Cuevas-Ferrando, E., Randazzo, W., Perez-Cataluna, A., Falco, I., Navarro, D., Martin-Latin, S., Diaz-Reolid, A., Giron-Guzman, I., Allende, A., Sanchez, G.
10.1101/2021.03.22.21253818 — Posted: 2021-03-26
Pregnancy and risk of COVID-19
Magnus, M., Oakley, L., Gjessing, H. K., Stephansson, O., Engjom, H. M., Macsali, F., Juliusson, P. B., Nybo Andersen, A.-M., Haberg, S. E.
10.1101/2021.03.22.21254090 — Posted: 2021-03-26
A rapid assessment of wastewater for genomic surveillance of SARS-CoV-2 variants at sewershed scale in Louisville, KY
Fuqua, J., Rouchka, E., Waigel, S., Sokoloski, K., Chung, D., Zacharias, W., Zhang, M., Chariker, J., Talley, D., Santisteban, I., Vasrsani, A., Moyer, S., Holm, R. H., Yeager, R., Smith, T. R., Bhatnagar, A.
10.1101/2021.03.18.21253604 — Posted: 2021-03-26
Supporting COVID-19 policy response with large-scale mobility-based modeling
Chang, S. Y., Wilson, M. L., Lewis, B., Mehrab, Z., Dudakiya, K. K., Pierson, E., Koh, P. W., Gerardin, J., Redbird, B., Grusky, D., Marathe, M., Leskovec, J.
10.1101/2021.03.20.21254022 — Posted: 2021-03-26
The health effects in the US of quarantine policies based on predicted individual risk of severe COVID-19 outcomes
Lovick, S. E., Dite, G. S., Allman, R.
10.1101/2021.03.21.21254065 — Posted: 2021-03-26
SARS-CoV-2 Acquisition and Immune Pathogenesis Among School-Aged Learners in Four K-12 Schools
Cooper, D. M., Messaoudi, i. R., Aizik, S., Camplain, R. L., Lopez, N. V., Ardo, J., Boden-Albala, B., Chau, C., Condon, C., Golden, C., Coimbra Ibraim, I., Jankeel, A., Kasper, K., Meyer, A., Stehli, A., Stephens, D., Weiss, M., Zulu, M. Z., Ulloa, E. R.
10.1101/2021.03.20.21254035 — Posted: 2021-03-26
A small number of early introductions seeded widespread transmission of SARS-CoV-2 in Quebec, Canada
Murall, C. L., Fournier, E., Galvez, J. H., N'Guessan, A., Reiling, S. J., Quirion, P.-O., Naderi, S., Roy, A.-M., Chen, S.-H., Stretenowich, P., Bourgey, M., Bujold, D., Gregoire, R., Lepage, P., St-Cyr, J., Willet, P., Dion, R., Charest, H., Lathrop, G. M., Roger, M., Bourque, G., Ragoussis, J., Shapiro, B. J., Moreira, S.
10.1101/2021.03.20.21253835 — Posted: 2021-03-26
Estimating the impact of interventions against COVID-19: from lockdown to vaccination
Thompson, J., Wattam, S.
10.1101/2021.03.21.21254049 — Posted: 2021-03-26
Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 RBD variants with a novel competitive multiplex assay
Lopez, E., Haycroft, E. R., Adair, A., Mordant, F. L., O'Neill, M., Pymm, P., Redmond, S., Gherardin, N. A., Whearley, A. K., Juno, J. A., Selva, K. J., Davis, S., Harty, L., Purcell, D. F. J., Subbarao, K., Godfrey, D. I., Kent, S. J., Tham, W.-H., Chung, A. W.
10.1101/2021.03.20.21254037 — Posted: 2021-03-26
COVID-19: A need for new rather than repurposed antiviral drugs.
Kovacs, D., Davis, C., Cannon, P., McFarlane, M., Rainey, S. M., Pinto, R., Stewart, M. E., Szemiel, A. M., Taggart, A., Kohl, A., Marra, F., Thomson, E. C., Scott, J. T.
10.1101/2021.03.25.436935 — Posted: 2021-03-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).